Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in 3 phase III North American studies

被引：0

作者：

Curry, Michael ^{[1
]}

Vargas, Hugo E. ^{[2
]}

Befeler, Alex ^{[3
]}

Pyrsopoulos, Nikolaos T. ^{[4
]}

Patwardhan, Vilas ^{[1
]}

Jamil, Khurram ^{[5
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[2] Mayo Clin, Rochester, MN USA

[3] St Louis Univ, St Louis, MO USA

[4] Rutgers New Jersey Med Sch, Univ Hosp, Newark, NJ USA

[5] Mallinckrodt Pharmaceut, Staines Upon Thames, England

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI537

引用

页码：S634 / S635

页数：2

共 50 条

[41] Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
Bird, Paul
Hall, Stephen
Nash, Peter
Connell, Carol A.
Kwok, Kenneth
Witcombe, David
Thirunavukkarasu, Krishan
RMD OPEN, 2019, 5 (01):
[42] Clinical characteristics and outcomes of black patients with mycosis fungoides and Sezary syndrome: a subgroup analysis of the phase III MAVORIC trial
Johnson, William T.
Kartan, Saritha
Sokol, Kelsey
Nikbakht, Neda
Porcu, Pierluigi
LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1877 - 1883
[43] Initial Report of a Large, Randomized, Double Blind, Placebo-controlled, Phase 3 Trial of Terlipressin plus Albumin for the Treatment of Type 1Hepatorenal Syndrome (HRS-1): The REVERSE Study
Boyer, Thomas D.
Sanyal, Arun J.
Wong, Florence
Frederick, R. Todd
Lake, John R.
O'Leary, Jacqueline G.
Ganger, Daniel
Box, Terry D.
Jamil, Khurram
Pappas, Stephen Chris
HEPATOLOGY, 2014, 60 : 255A - 255A
[44] Efficacy and safety outcomes with odevixibat treatment: Pooled data from the phase 3 ASSERT and ASSERT-EXT studies in patients with Alagille syndrome
Ovchinsky, Nadia
Aumar, Madeleine
Baker, Alastair
Baumann, Ulrich
Bufler, Philip
Cananzi, Mara
Durmaz, Ozlem
Fischer, Ryan
Indolfi, Giuseppe
Karnsakul, Wikrom
Lacaille, Florence
Lee, Way Seah
Maggiore, Giuseppe
Rosenthal, Philip
Ruiz, Mathias
Sokal, Etienne
Sturm, Ekkehard
van der Woerd, Wendy L.
Verkade, Henkjan J.
Wehrman, Andrew
Clemson, Christine
Yu, Qifeng
Ni, Quanhong
Ruvido, Jessica
Manganaro, Susan
Mattsson, Jan
Czubkowski, Piotr
JOURNAL OF HEPATOLOGY, 2023, 78 : S965 - S966
[45] Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
Klotz, Laurence
Tat, Tri
BJUI COMPASS, 2024, 5 (03): : 392 - 402
[46] Patient-reported outcomes with sarecycline treatment for Acne Vulgaris: Pooled analysis of phase 3 clinical studies
Harper, J.
Armstrong, A.
Fried, R.
Rieder, E.
Alvarez-Dieppa, A.
Grada, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (09) : B12 - B12
[47] Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies
Harper, Julie C.
Armstrong, April
Fried, Richard G.
Rieder, Evan A.
Alexis, Andrew F.
Salem, Raidah J.
Kasujee, Ismail
Grada, Ayman
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (04) : 832 - 834
[48] Cost Savings and Improved Clinical Outcomes of Early Insulin in Patients Treated with 2 vs 3 Oral Antidiabetic Agents
Vinik, Aaron
Zhang, Quanwu
Gerich, John
DIABETES, 2010, 59 : A71 - A71
[49] Efficacy of Secukinumab Treatment in Patients with Early Psoriatic Arthritis: A Pooled Analysis of 4 Phase 3 Studies
Ritchlin, Christopher
Kivitz, Alan
Nash, Peter
Calheiros, Renato
Meng, Xiangyi
Gaillez, Corine
Kirkham, Bruce
McInnes, Iain
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[50] Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
Dryden, Matthew
Kantecki, Michal
Yan, Jean Li
Stone, Gregory G.
Leister-Tebbe, Heidi
Wilcox, Mark
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 108 - 114

← 1 2 3 4 5 →